
|Articles|August 10, 2011
Blood Pressure, Circulation Supplement to Enter Clinical Trial
Dietary supplements brand Nathans Natural announced that its Levodyn supplement will begin a Phase II clinical trial.
Advertisement
Dietary supplements brand Nathans Natural announced that its Levodyn supplement will begin a Phase II clinical trial to study its safety and efficacy in lowering blood pressure and improving blood circulation in mildly hypertensive subjects.
The company says that the trial will be a double-blind, randomized, placebo-controlled, parallel-group, multicenter study. It will be performed by contract research organization Vedic Lifesciences (Redwood Shores, CA).
Advertisement
Advertisement
Advertisement
Trending on Nutritional Outlook - Supplement, Food & Beverage Manufacturing Trends
1
A New Frontier in Eye Health: Digital Wellness, Bioavailability, and the Eye-Brain Connection
2
Clasado Biosciences Partners with Prokopton SAS to Expand Bimuno GOS Distribution in France
3
Finished Product Clinical Validation Emerges as a Competitive Differentiator in the Supplement Industry
4
Lion’s Mane Ingredient Targets Standardized Erinacine A
5





